Cancer support group

Global Real Estate Brokerage The Agency Launches First Office in Mallorca, Spain

Retrieved on: 
Wednesday, February 22, 2023

LOS ANGELES, Feb. 22, 2023 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its new franchise office in Mallorca, Spain. The new locale is the firm's third office in Europe, following Lisbon, Portugal and The Netherlands. The office joins the brokerage's growing network of more than 70 offices in the U.S., Canada, Mexico, the Caribbean, and Europe. The Mallorca office will be led by industry veteran and Managing Partner, Alby Euesden.

Key Points: 
  • LOS ANGELES, Feb. 22, 2023 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its new franchise office in Mallorca, Spain.
  • The Agency is an agent-first, tech-driven boutique luxury global brokerage representing clients worldwide in a broad spectrum of classes, including residential, new development, resort real estate, luxury leasing and vacation rentals.
  • The Agency has closed more than $57 billion real estate transactions since 2011, comprising over 70 offices in ten countries, and counting, as one of the fastest-growing boutique, luxury real estate brands in the world.
  • Watch The Agency on Buying Beverly Hills, a new real estate occu-soap highlighting the high-stakes world of luxury real estate in Los Angeles, currently streaming on Netflix.

Chiesi Global Rare Diseases Announces Results from Study Evaluating Economic Burden of Rare Diseases and Launches Second Annual #WeWearStripes Campaign on Rare Disease Day

Retrieved on: 
Monday, February 28, 2022

The company is also recognizing Rare Disease Day 2022 with the launch of the second annual #WeWearStripes for the Rare Ones social media campaign.

Key Points: 
  • The company is also recognizing Rare Disease Day 2022 with the launch of the second annual #WeWearStripes for the Rare Ones social media campaign.
  • "Every year Rare Disease Day brings together more than 300 million people affected by rare diseases around the world in a collective effort to build broader awareness and call for new treatment options," said Giacomo Chiesi, head of Chiesi Global Rare Diseases and co-author of the study.
  • Results demonstrated that rare diseases impose a substantial economic burden that can be reduced with availability of new treatments.
  • "The results of this study are clear - access to therapies for people living with rare diseases generates significant value for society.

Cancer Research UK and Abcam Launch Custom Partnership to Accelerate Cancer Research

Retrieved on: 
Tuesday, July 7, 2020

Under the terms of the partnership, Abcam will develop custom protein-based reagents to targets identified by Cancer Research UK-funded researchers.

Key Points: 
  • Under the terms of the partnership, Abcam will develop custom protein-based reagents to targets identified by Cancer Research UK-funded researchers.
  • Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
  • Cancer Research UK's commercial activity operates through Cancer Research Technology Ltd., a wholly owned subsidiary of Cancer Research UK.
  • Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.

Cancer Research UK and Abcam Launch Custom Partnership to Accelerate Cancer Research

Retrieved on: 
Tuesday, July 7, 2020

Under the terms of the partnership, Abcam will develop custom protein-based reagents to targets identified by Cancer Research UK-funded researchers.

Key Points: 
  • Under the terms of the partnership, Abcam will develop custom protein-based reagents to targets identified by Cancer Research UK-funded researchers.
  • Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
  • Cancer Research UK's commercial activity operates through Cancer Research Technology Ltd., a wholly owned subsidiary of Cancer Research UK.
  • Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.

Helping Veterans Across New Jersey, So That No One Faces Cancer Alone Cancer Support Community Central New Jersey Joins Forces with Warrior Centric Healthcare Foundation

Retrieved on: 
Wednesday, May 20, 2020

"Our partnership with CSCCNJ ensures we can deliver on the promise to ' care for THOSE who have borne the battle.'"

Key Points: 
  • "Our partnership with CSCCNJ ensures we can deliver on the promise to ' care for THOSE who have borne the battle.'"
  • Belardo heard about CSCCNJ through a fellow veteran who insisted that he should attend the Men's Cancer Support Group, which is the organization's entry point for many veterans.
  • For people with cancer, including veterans, Belardo says, "What Cancer Support Community Central New Jersey does, beyond anything, is provide a place for hope."
  • About Cancer Support Community Central New Jersey:
    Cancer Support Community Central New Jersey (CSCCNJ) is a registered 501c(3) and an independent licensed affiliate of Cancer Support Community, an international nonprofit organization.

Lineage Cell Therapeutics Announces Early Exercise of Option with Cancer Research UK for Immuno-Oncology Cell Therapy Program

Retrieved on: 
Thursday, May 7, 2020

This decision was based on an early review of the data collected by Cancer Research UK in the VAC2 trial under a clinical trial and option agreement.

Key Points: 
  • This decision was based on an early review of the data collected by Cancer Research UK in the VAC2 trial under a clinical trial and option agreement.
  • Cancer Research UK is the worlds largest cancer charity dedicated to saving lives through research.
  • Cancer Research UKs commercial activity operates through Cancer Research Technology Ltd., a wholly owned subsidiary of Cancer Research UK.
  • Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.

Cancer Hope Network Names Tom Bongiorno and Dave Ondrejcak to Board of Trustees

Retrieved on: 
Wednesday, January 22, 2020

"Ever since that experience, I've been committed to the mission of providing hope for patients and caregivers facing cancer.

Key Points: 
  • "Ever since that experience, I've been committed to the mission of providing hope for patients and caregivers facing cancer.
  • Tom and Diane received CHN's Spirit of Hope award in 2018, recognizing them as an "extraordinary source of support to Cancer Hope Network."
  • "Tom has been a part of the Cancer Hope Network family for many years," says Executive Director Cynthia Gutierrez Bernstein.
  • Cancer Hope Network provides free one-on-one emotional peer support to adult cancer patients and their loved ones.

Strengthening Our Schools: Cancer Support Community CNJ Provides Education and Support to the School Communities

Retrieved on: 
Wednesday, December 4, 2019

Every week in New Jersey, there are almost 1,000 new cases of cancer according to the American Cancer Society.

Key Points: 
  • Every week in New Jersey, there are almost 1,000 new cases of cancer according to the American Cancer Society.
  • This conference provides information and resources to professionals in these communities and makes them aware of the services available to their schools.
  • By working with school professionals, CSCCNJ services are leveraged to help activate school communities to support the emotional and social needs of students, especially for those affected by cancer.
  • About Cancer Support Community Central New Jersey: Cancer Support Community Central New Jersey (CSCCNJ) is a registered 501c(3) and an independently licensed affiliate of Cancer Support Community, an international nonprofit organization.

BioInvent Signs Manufacturing Agreement With Cancer Research UK Expected to Generate Approximately SEK 30 Million (~$3 Million)

Retrieved on: 
Wednesday, October 23, 2019

Under the agreement, which is expected to generate revenue of approximately SEK 30 million (~$3 million), mostly in 2020, BioInvent will provide HMBD-001 to Cancer Research UK.

Key Points: 
  • Under the agreement, which is expected to generate revenue of approximately SEK 30 million (~$3 million), mostly in 2020, BioInvent will provide HMBD-001 to Cancer Research UK.
  • Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
  • Cancer Research UK receives no funding from the UK government for its life-saving research.
  • Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.

BioInvent Signs Manufacturing Agreement With Cancer Research UK Expected to Generate Approximately SEK 30 Million (~$3 Million)

Retrieved on: 
Wednesday, October 23, 2019

Under the agreement, which is expected to generate revenue of approximately SEK 30 million (~$3 million), mostly in 2020, BioInvent will provide HMBD-001 to Cancer Research UK.

Key Points: 
  • Under the agreement, which is expected to generate revenue of approximately SEK 30 million (~$3 million), mostly in 2020, BioInvent will provide HMBD-001 to Cancer Research UK.
  • Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
  • Cancer Research UK receives no funding from the UK government for its life-saving research.
  • Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.